Home › Plexiform Neurofibroma › Alabama
Plexiform Neurofibroma clinical trials in Alabama
4 studies for Plexiform Neurofibroma are looking for participants at sites in Alabama.
Cities in Alabama
Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas
- Childrens of Alabama, Birmingham
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Aug 24, 2026 · NCT06502171A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 2
Ages 12 and older · All sexes · Updated Jul 29, 2026 · NCT06541847Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Childrens of Alabama, Birmingham
RecruitingPhase 2
Ages 1 to 8 · All sexes · Updated May 29, 2026 · NCT06188741PAS-004 in Adults Who Have Neurofibromatosis Type 1 With Plexiform Neurofibromas
- University of Alabama at Birmingham, Birmingham
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Dec 4, 2025 · NCT06961565From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.